Toward a definition of pharmacoresistant neuropathic pain

European Journal of Pain

Volumn 13, Issue 5, 2009, Pages 439-440

  Hansson, Per T ^a   Attal, Nadine ^b,c,d   Baron, Ralf ^e   Cruccu, Giorgio ^f  

^a Section of Clinical Pain Research   (Sweden)

^b INSERM U 987   (France)

^c HÔPITAL AMBROISE PARÉ   (France)

^d LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^e UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^f SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; CARBAMAZEPINE; DULOXETINE; GABAPENTIN; LIDOCAINE; METHADONE; MORPHINE; NORTRIPTYLINE; OPIATE DERIVATIVE; OXCARBAZEPINE; OXYCODONE; PREGABALIN; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SODIUM CHANNEL BLOCKING AGENT; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ANALGESIA; CLINICAL PRACTICE; DIABETIC NEUROPATHY; EDITORIAL; HUMAN; NEUROPATHIC PAIN; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT RESPONSE; TRIGEMINUS NEURALGIA;

ANALGESICS; CLINICAL TRIALS AS TOPIC; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; EVIDENCE-BASED MEDICINE; HUMANS; NEURALGIA; NEUROPHARMACOLOGY; PAIN, INTRACTABLE; PERIPHERAL NERVOUS SYSTEM DISEASES; QUALITY OF LIFE; TREATMENT FAILURE;

EID: 63649122605     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1016/j.ejpain.2009.02.008     Document Type: Editorial

References (14)

1. Attal N., Cruccu G., Haanpaa M., Hansson P., Jensen T.S., Nurmikko T., et al. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 13 (2006) 1153-1169
2. Attal N., Fermanian C., Fermanian J., Lanteri-Minet M., Alchaar H., and Bouhassira D. Neuropathic pain: are there distinct subtypes depending on the aetiology or anatomical lesion?. Pain 138 (2008) 343-353
3. Baron R. Mechanisms of disease: neuropathic pain - a clinical perspective. Nat Clin Pract Neurol 2 (2006) 95-106
4. Cruccu G. Treatment of painful neuropathy. Curr Opin Neurol 20 (2007) 531-535
5. Cruccu G., Aziz T.Z., Garcia-Larrea L., Hansson P., Jensen T.S., Lefaucheur J.P., et al. EFNS guidelines on neurostimulation therapy for neuropathic pain. Eur J Neurol 14 (2007) 952-970
6. Dworkin R.H., O'Connor A.B., Backonja M., Farrar J.T., Finnerup N.B., Jensen T.S., et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 132 (2007) 237-251
7. Farrar J.T., Young Jr. J.P., LaMoreaux L., Werth J.L., and Poole R.M. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 94 (2001) 149-158
8. Finnerup N.B., Otto M., McQuay H.J., Jensen T.S., and Sindrup S.H. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 118 (2005) 289-305
9. Gilron I., Bailey J.M., Tu D., Holden R.R., Weaver D.F., and Houlden R.L. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 352 (2005) 1324-1334
10. Hanna M., O'Brien C., and Wilson M.C. Prolonged-release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients. Eur J Pain 12 (2008) 804-813
11. Hansson P.T., and Dickenson A.H. Pharmacological treatment of peripheral neuropathic pain conditions based on shared commonalities despite multiple etiologies. Pain 113 (2005) 251-254
12. Simpson D.A. Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy. J Clin Neuromuscul Dis 3 2 (2001) 53-62
13. Williams J.A., Day M., and Heavner J.E. Ziconotide: an update and a review. Expert Opin Pharmacother 9 9 (2008) 1575-1583
14. Woolf C.J., Bennett G.J., Doherty M., Dubner R., Kidd B., Koltzenburg M., et al. Towards a mechanism-based classification of pain?. Pain 77 (1998) 227-229